€96.00
Stenabolic
4-6 hours
PPAR alpha modifier
20-30 mg/day
No
See Document
SR9009, Stenabolic
USA Warehouse 2
No significant impact reported
Not available under any trade name as it is not commercially marketed
Store at room temperature, away from moisture and light
Ethyl 3-[[(4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino]methyl]pyrrolidine-1-carboxylate
C20H24ClN3O4S
Synthetic drug, Rev-ErbA ligand
Activates Rev-ErbA which increases mitochondrial count in muscle, decreases fat storage
Approximately 4-5 hours
Not clinically approved for medical use
Typically 10-40 mg per day
Increased endurance, reduced fat mass, increased wakefulness
Potential alterations in circadian rhythms, limited data on long-term effects
Used as a performance-enhancing drug, not approved by WADA
Spectre Labs
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your Rating Rate… Perfect Good Average Not that bad Very Poor
Your Review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
There are no reviews yet.